Education
Bradley W. Christensen, M.D., is hematologist and medical oncologist at Texas Oncology - Charles A. Sammons Cancer Center. He specializes in leukemia, lymphoma, and multiple myeloma and has expertise in non-malignant hematologic conditions including clotting and bleeding disorders and disorders of red blood cells and platelets.
Dr. Christensen earned his undergraduate and medical degrees from Texas A&M University. He completed a residency in internal medicine at Vanderbilt University Medical Center, where he served as a Chief Resident, and then gained advanced training at UT-Southwestern in hematology and oncology. He is also certified by the American Board of Internal Medicine in internal medicine, hematology, and oncology. He joined Texas Oncology-Baylor Charles A. Sammons Cancer Center in 2022.
Dr. Christensen’s main clinical and research interests are the management of indolent and aggressive lymphomas and immune effector cell therapies. He has presented research at the American Society of Hematology national meeting and authored peer-reviewed publications on the toxicity of targeted and immune effector cell therapies. He is the principal investigator on multiple clinical trials in lymphoma and leukemia and is a member of the Texas Oncology Hematology Multidisciplinary Pathways Committee.
Dr. Christensen is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the Texas Medical Association. o Outside of work, Dr. Christensen enjoys spending time with his wife and 3 kids, playing basketball and tennis, watching the World Champion Texas Rangers, and reading books on spirituality and the history of medicine.
Accolades & Memberships
- Alpha Omega Alpha
- American Medical Association
- American Society of Clinical Oncology
- American Society of Hematology
- Chief Resident, Vanderbilt University Medical Center (2018 –2019)
- Fellow Clinical Trial Enrollment Award, The University of Texas Southwestern Medical Center (2020 – 2021)
- The Gold Humanism Honor Society
Why a patient should choose treatment at your practice?
Texas Oncology provides treatment and hope to more Texans than any other healthcare provider. With more than 530 physicians and 280 care-delivery locations, we use the same cancer-fighting technology and therapies found in the top cancer centers in America.
Texas Oncology offers a full range of oncology services, including chemotherapy, radiation, laboratory testing, clinical trials and support services, all conveniently located in the familiar setting of your community. Our practices participate in national clinical trials, and our research played a pivotal role in developing more than 100 of the latest FDA-approved cancer drugs.
What is your personal philosophy around patient care?
For me, patient care begins and ends with a genuine love for people and a willingness to spend the time necessary to help them. To be a patient is to be vulnerable; it is to trust another human being with something as precious as his/her health. I consider that trust to be a grave responsibility and I do not take it lightly. A physician, and especially an oncologist, is a healer only to the extent that they have expertise in their field and put the interests of their patients first. I believe that every patient deserves those qualities, and I work hard to cultivate them in myself.